These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33234694)

  • 1. Automated digital enumeration of plasma cells in bone marrow trephine biopsies of multiple myeloma.
    Malherbe JAJ; Fuller KA; Mirzai B; Augustson BM; Erber WN
    J Clin Pathol; 2022 Jan; 75(1):50-57. PubMed ID: 33234694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry.
    Al-Quran SZ; Yang L; Magill JM; Braylan RC; Douglas-Nikitin VK
    Hum Pathol; 2007 Dec; 38(12):1779-87. PubMed ID: 17714757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new technique using artificial intelligence for quantification of plasma cells on CD138 immunohistochemistry.
    Gantana EJ; Nell EM; Musekwa E; Lohlun RK; Chetty C; Moodley K; Chabunya S; Ras J; Chapanduka ZC
    Int J Lab Hematol; 2024 Feb; 46(1):50-57. PubMed ID: 37621174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an innovative new method for quantitation of plasma cells on CD138 immunohistochemistry.
    Gantana E; Mashigo N; Abdullah I; Musekwa E; Lohlun R; Nell EM; Chetty C; Ntobongwana M; Chapanduka Z
    J Clin Pathol; 2023 Apr; 76(4):261-265. PubMed ID: 34625512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry.
    Matsue K; Matsue Y; Kumata K; Usui Y; Suehara Y; Fukumoto K; Fujisawa M; Narita K; Takeuchi M
    Hematol Oncol; 2017 Sep; 35(3):323-328. PubMed ID: 27140172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.
    Ng AP; Wei A; Bhurani D; Chapple P; Feleppa F; Juneja S
    Haematologica; 2006 Jul; 91(7):972-5. PubMed ID: 16818287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated enumeration of lymphoid and plasma cells in bone marrow to establish normal reference ranges.
    Liang J; Malherbe JAJ; Fuller KA; Mirzai B; George C; Carter TL; Cole CH; Guo BB; Meehan K; Erber WN
    J Clin Pathol; 2018 Oct; 71(10):916-925. PubMed ID: 29858232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma.
    Stifter S; Babarović E; Valković T; Seili-Bekafigo I; Stemberger C; Nacinović A; Lucin K; Jonjić N
    Diagn Pathol; 2010 May; 5():30. PubMed ID: 20482792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
    Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
    Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A counting strategy for estimating plasma cell number in CD138-stained bone marrow core biopsy sections.
    Smith FB; Elnawawi A
    Ann Clin Lab Sci; 2008; 38(2):138-42. PubMed ID: 18469359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
    Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
    Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow trephine combined with immunohistochemistry is superior to bone marrow aspirate in follow-up of myeloma patients.
    Joshi R; Horncastle D; Elderfield K; Lampert I; Rahemtulla A; Naresh KN
    J Clin Pathol; 2008 Feb; 61(2):213-6. PubMed ID: 17526802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Audit of bone marrow aspirates and trephine biopsies in multiple myeloma--a single centre study.
    Charles KS; Winfield DA; Angel C; Goepel J
    Clin Lab Haematol; 2004 Dec; 26(6):403-6. PubMed ID: 15595998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression.
    Rawstron A; Barrans S; Blythe D; Davies F; English A; Pratt G; Child A; Morgan G; Jack A
    Br J Haematol; 1999 Jan; 104(1):138-43. PubMed ID: 10027726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haematologists usually over-estimate the percentage of CD138+ plasma cells in marrow biopsies.
    Chai KY; Boyke Berahmana AA; Morison IM
    Pathology; 2019 Oct; 51(6):647-648. PubMed ID: 31470997
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of an open-source machine-learning tool to quantify bone marrow plasma cells.
    Baranova K; Tran C; Plantinga P; Sangle N
    J Clin Pathol; 2021 Jul; 74(7):462-468. PubMed ID: 33952591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells.
    Ak I; Aslan V; Vardareli E; Gülbaş Z
    Ann Hematol; 2003 Feb; 82(2):88-92. PubMed ID: 12601486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenging task of enumerating blasts in the bone marrow.
    Hodes A; Calvo KR; Dulau A; Maric I; Sun J; Braylan R
    Semin Hematol; 2019 Jan; 56(1):58-64. PubMed ID: 30573046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies.
    Chilosi M; Adami F; Lestani M; Montagna L; Cimarosto L; Semenzato G; Pizzolo G; Menestrina F
    Mod Pathol; 1999 Dec; 12(12):1101-6. PubMed ID: 10619261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.